Companies · Medical Devices

Ideal Implant Inc

DALLAS · Medical Devices · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Ideal Implant Inc — recommendation, valuation, rhythm, risks.
$16.8M
Total raised · real
7
Rounds
0.8×
Latest step-up
Top 15%
Sector rank · raised
Series A
Latest stage · inferred · Wed Oct 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Ideal Implant Inc looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.00× the median modeled value of Series A Medical Devices companies in 2019–2021 (17 peers) — value vs value, same stage and era.
  • Within the normal band (100% of peer median) for its niche.
Dormant
  • Last raise 5.7 yr ago; this sector typically re-raises about every 16 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Medical Devices

Ideal Implant Inc is one of 233 Medical Devices companies tracked from DALLAS. By capital raised it ranks in the upper tier (ahead of 86% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

medical-devices

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
13
Investors (latest)
2020-10-21
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2010-05-24 Raised $1.7M (real) Modeled valuation $49M (est)Seed2010Seed · 2016-08-23 Raised $416K (real) Modeled valuation $12M (est)Seed2016Seed · 2017-05-18 Raised $500K (real) Modeled valuation $15M (est)Seed2017Series A · 2017-12-27 Raised $4.9M (real) Modeled valuation $119M (est)Series A2017Series A · 2019-09-27 Raised $3.9M (real) Modeled valuation $95M (est)Series A2019Series A · 2020-03-31 Raised $3.1M (real) Modeled valuation $74M (est)Series A2020Series A · 2020-10-21 Raised $2.3M (real) Modeled valuation $49M (est)Series A2020+$416K+$500K+$4.9M+$3.9M+$3.1M+$2.3MCumulative $17M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.7M · 2010
Seed extension$416K · 2016
Seed extension$500K · 2017
Series A$4.9M · 2017
Series A extension$3.9M · 2019
Series A extension$3.1M · 2020
Series A extension$2.3M · 2020

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$49.4M
Base estimate est.
$2.8M
Conservative case
$250.4M
Upside case
$10.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.

Seed · modeled $49.3M · 2010-05-242010Seed · modeled $12.3M · 2016-08-23Seed · modeled $14.8M · 2017-05-18Series A · modeled $119.1M · 2017-12-27Series A · modeled $95.0M · 2019-09-27Series A · modeled $74.2M · 2020-03-31Series A · modeled $49.4M · 2020-10-212020
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
50%
Survival probability
27% low · 68% high
1.49×/yr
Annual markup
1.87×/yr upside case
5.7 yr
Elapsed time used
5.7 yr actual, capped for stale marks
medical devices
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
21 mo
Avg between rounds
$1.6M/yr
Capital velocity
16.1 yr
On record since
2010
First round
7
Rounds on file
How it compares to the market

Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 6.6× above median
This company$16.8M
Sector median$2.6M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.5× of median
This company$2.3M
Sector median$4.6M
Modeled value — vs sector median (estimate, all stages) 3.2× above median
This company$49.4M
Sector median$15.4M

Raised more than 86% of sector peers (real $). Modeled value above 77% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #9 of 17.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Reliant Immune Diagnostics, Inc. · Series A Raised $10.9M · modeled $262.4M (est)Pristine Surgical LLC · Series A Raised $14.2M · modeled $201.7M (est)Predictive Health Diagnostics Co. · Series A Raised $8.3M · modeled $154.8M (est)Juno Diagnostics, Inc. · Series A Raised $6.3M · modeled $107.9M (est)Allotrope Medical Inc. · Series A Raised $5.0M · modeled $93.6M (est)Surgical Innovation Associates Inc. · Series A Raised $8.9M · modeled $86.9M (est)CAIRA Surgical Corp · Series A Raised $5.2M · modeled $85.4M (est)Sandstone Diagnostics Inc · Series A Raised $14.0M · modeled $52.0M (est)ExplORer Surgical Corp. · Series A Raised $11.2M · modeled $45.9M (est)Nanomedical Diagnostics, Inc. · Series A Raised $12.0M · modeled $38.0M (est)Precise Light Surgical, Inc. · Series A Raised $14.2M · modeled $35.2M (est)Ideal Implant Inc (this company) Raised $16.8M · modeled $49.4M (est)Ideal Implant Inc
CompanyStageRaised · realValue · estvs peer med.
Reliant Immune Diagnostics, Inc.Series A$10.9M$262.4M5.31×
Pristine Surgical LLCSeries A$14.2M$201.7M4.08×
Predictive Health Diagnostics Co.Series A$8.3M$154.8M3.13×
Juno Diagnostics, Inc.Series A$6.3M$107.9M2.18×
Allotrope Medical Inc.Series A$5.0M$93.6M1.90×
Surgical Innovation Associates Inc.Series A$8.9M$86.9M1.76×
CAIRA Surgical CorpSeries A$5.2M$85.4M1.73×
Sandstone Diagnostics IncSeries A$14.0M$52.0M1.05×
Ideal Implant Inc this companySeries A$16.8M$49.4M1.00×
ExplORer Surgical Corp.Series A$11.2M$45.9M0.93×
Nanomedical Diagnostics, Inc.Series A$12.0M$38.0M0.77×
Precise Light Surgical, Inc.Series A$14.2M$35.2M0.71×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.7M2010-05-24$8.3M$49.3M85%
Seed$416K2016-08-23$2.1M$12.3M85%
Seed$500K2017-05-18$2.5M$14.8M90%
Series A$4.9M2017-12-27$22.4M$119.1M90%
Series A$3.9M2019-09-27$17.9M$95.0M90%
Series A$3.1M2020-03-31$14.0M$74.2M90%
Series A$2.3M2020-10-21$10.5M$49.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.7M2010-05-24
    • First recorded raise — entered as Seed.
    • 38 investors on this round.
  2. Seed$416K2016-08-23
    • Raised again after 75 mo — slower than the ~16 mo sector norm.
    • Round 4.0× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 7 investors on this round.
  3. Seed$500K2017-05-18
    • Came back fast: 9 mo vs the ~16 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  4. Series A$4.9M2017-12-27
    • Came back fast: 7 mo vs the ~16 mo sector norm.
    • Round 9.9× larger than the prior — scaling up.
    • 13 investors on this round.
  5. Series A$3.9M2019-09-27
    • Raised 21 mo later, in step with the ~16 mo sector norm.
    • Round roughly the size of the prior one.
    • 24 investors on this round.
  6. Series A$3.1M2020-03-31
    • Came back fast: 6 mo vs the ~16 mo sector norm.
    • Round roughly the size of the prior one.
    • 17 investors on this round.
  7. Series A$2.3M2020-10-21
    • Came back fast: 7 mo vs the ~16 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 13 investors on this round.
Intelligence
2022 ~Q3
Modeled next raise · ~21mo cadence
$2.3M
Modeled next size est.range $2.3M$3.7M
0.8×
Last step-up
$1.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Wade B. Hampton1 other2010-05
David B. Rasmussen, MD2016-08
David L. Rasmussen. MD2010-05
Kevin B. Morano2016-08
Kevin B. Morano, MBA2010-05
Paul B. Herchman2017-12
Robert S. Hamas, M.D.2010-05
Ryan B. Weldon2016-08
Registry & provenance

Ideal Implant Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1360739
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
New View Surgical, Inc.Medical DevicesSeries A$15.8M$70.8Msame sector · same stage
Prescient Surgical, Inc.Medical DevicesSeries A$15.6M$3.5Msame sector · same stage
Pristine Surgical LLCMedical DevicesSeries A$14.2M$201.7Msame sector · same stage
Precise Light Surgical, Inc.Medical DevicesSeries A$14.2M$35.2Msame sector · same stage
Sandstone Diagnostics IncMedical DevicesSeries A$14.0M$52.0Msame sector · same stage
Acuamark Diagnostics, Inc.Medical DevicesSeries A$20.3M$25.6Msame sector · same stage
Bayou Surgical, Inc.Medical DevicesSeries A$13.2M$14.8Msame sector · same stage
Black Light Surgical, Inc.Medical DevicesSeries A$12.9M$6.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
IC Surgical, Inc.Medical DevicesPre-Seed$5.5M82%
Optimotion Implants LlcOther Health CareSeed$19.9M81%
Smart Step Surgical LLCMedical DevicesPre-Seed$1.7M81%
OnPoint Surgical, Inc.Medical DevicesPre-Seed$7.4M81%
EDGe Surgical, Inc.Medical DevicesSeries A$3.6M80%
Surgical Innovation Associates Inc.Medical DevicesSeries A$86.9M80%
Active Implants LLCOther Health CareSeries C$84.3M80%
ACTIV Surgical, Inc.Medical DevicesSeries C$240.1M80%
Frequently asked
How much funding has Ideal Implant Inc raised?
Ideal Implant Inc has raised approximately $16.8M in disclosed capital across 7 recorded financing rounds, aggregated from public filings.
What is Ideal Implant Inc's estimated valuation?
Provath's modeled valuation for Ideal Implant Inc is approximately $49.4M (modeled range $2.8M–$250.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Ideal Implant Inc at?
Ideal Implant Inc's latest modeled financing stage is Series A. Its most recent recorded round closed around Wed Oct 21.
What does Ideal Implant Inc do and where is it based?
Ideal Implant Inc operates in the Medical Devices sector, based in DALLAS.
Explore related

See where Ideal Implant Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Ideal Implant Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.